Chemed Co. (NYSE:CHE) Shares Bought by Nuveen Asset Management LLC

Nuveen Asset Management LLC raised its stake in Chemed Co. (NYSE:CHE - Free Report) by 18.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,451 shares of the company's stock after buying an additional 6,005 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.26% of Chemed worth $20,901,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc purchased a new stake in Chemed in the 4th quarter valued at $29,000. CBIZ Investment Advisory Services LLC grew its holdings in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares in the last quarter. Tortoise Investment Management LLC grew its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after buying an additional 34 shares in the last quarter. Finally, Brown Brothers Harriman & Co. grew its holdings in shares of Chemed by 633.3% during the 4th quarter. Brown Brothers Harriman & Co. now owns 88 shares of the company's stock worth $47,000 after purchasing an additional 76 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Performance

Shares of NYSE CHE traded down $0.76 during mid-day trading on Thursday, reaching $571.75. 8,165 shares of the company's stock were exchanged, compared to its average volume of 118,323. The firm has a market capitalization of $8.36 billion, a price-to-earnings ratio of 28.89, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.60. The company's 50-day moving average is $582.04 and its 200-day moving average is $565.74.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same period in the prior year, the business posted $5.20 EPS. The company's revenue was up 9.8% compared to the same quarter last year. As a group, equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date is Thursday, May 29th. Chemed's dividend payout ratio (DPR) is 9.74%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of research analyst reports. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada increased their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the completion of the transaction, the chief executive officer now directly owns 101,197 shares in the company, valued at $58,335,010.65. This trade represents a 1.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold 7,500 shares of company stock worth $4,401,120 in the last three months. 3.29% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.